James M. Dambrosia

12.7k total citations · 3 hit papers
87 papers, 9.2k citations indexed

About

James M. Dambrosia is a scholar working on Neurology, Epidemiology and Physiology. According to data from OpenAlex, James M. Dambrosia has authored 87 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 23 papers in Epidemiology and 15 papers in Physiology. Recurrent topics in James M. Dambrosia's work include Lysosomal Storage Disorders Research (13 papers), Acute Ischemic Stroke Management (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). James M. Dambrosia is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Acute Ischemic Stroke Management (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). James M. Dambrosia collaborates with scholars based in United States, Canada and Italy. James M. Dambrosia's co-authors include Karin B. Nelson, Judith K. Grether, Marinos C. Dalakas, Terry M. Phillips, Norman W. Barton, Roscoe O. Brady, Daniel P. Stein, Carlos Otero, Suvimol Hill and Steven Dinsmore and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

James M. Dambrosia

86 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease

1991 981 citations Norman W. Barton, Roscoe O. Brady et al. New England Journal of Medicine profile →
A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis

1993 747 citations Marinos C. Dalakas, Isabel Illa et al. New England Journal of Medicine profile →
Functional relevance of cross-modal plasticity in blind humans

1997 643 citations Leonardo Cohen, Pablo Celnik et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James M. Dambrosia United States	50	2.7k	2.5k	2.0k	1.3k	1.2k	87	9.2k
Joseph E. Parisi United States	62	1.2k 0.4×	6.6k 2.6×	1.5k 0.7×	823 0.6×	2.1k 1.8×	180	16.0k
Jan Bauer Austria	68	1.3k 0.5×	2.5k 1.0×	1.5k 0.7×	529 0.4×	1.8k 1.5×	221	14.5k
Colin Smith United Kingdom	53	2.7k 1.0×	3.7k 1.5×	1.6k 0.8×	449 0.3×	1.2k 1.0×	210	11.0k
William Stewart United States	56	4.8k 1.7×	5.4k 2.1×	1.0k 0.5×	446 0.3×	1.7k 1.4×	226	12.3k
Nicholas M. Barbaro United States	62	1.2k 0.4×	2.8k 1.1×	1.4k 0.7×	2.3k 1.7×	3.1k 2.7×	161	11.9k
Nobuhito Saito Japan	46	1.8k 0.7×	3.0k 1.2×	349 0.2×	880 0.7×	976 0.8×	520	9.2k
Frank Mastaglia Australia	55	2.6k 0.9×	2.5k 1.0×	657 0.3×	1.7k 1.3×	1.3k 1.1×	336	10.0k
Hannu Kalimo Finland	70	989 0.4×	3.2k 1.3×	2.4k 1.2×	374 0.3×	2.5k 2.2×	312	15.4k
P. Montagna Italy	54	1.3k 0.5×	2.1k 0.8×	1.3k 0.6×	1.8k 1.4×	923 0.8×	241	9.2k
Margaret R. Wallace United States	44	935 0.3×	3.5k 1.4×	854 0.4×	320 0.2×	1.4k 1.2×	157	9.0k

Countries citing papers authored by James M. Dambrosia

Since Specialization

Citations

This map shows the geographic impact of James M. Dambrosia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Dambrosia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Dambrosia more than expected).

Fields of papers citing papers by James M. Dambrosia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Dambrosia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Dambrosia. The network helps show where James M. Dambrosia may publish in the future.

Co-authorship network of co-authors of James M. Dambrosia

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Dambrosia. A scholar is included among the top collaborators of James M. Dambrosia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Dambrosia. James M. Dambrosia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dalakas, Marinos C., Goran Rakočević, James M. Dambrosia, Harry Alexopoulos, & Beverly McElroy. (2017). A double‐blind, placebo‐controlled study of rituximab in patients with stiff person syndrome. Annals of Neurology. 82(2). 271–277. 73 indexed citations

Dalakas, Marinos C., Goran Rakočević, Mohammad Salajegheh, et al.. (2009). Placebo‐controlled trial of rituximab in IgM anti–myelin‐associated glycoprotein antibody demyelinating neuropathy. Annals of Neurology. 65(3). 286–293. 217 indexed citations

Dalakas, M. C., Goran Rakočević, Jan Schmidt, et al.. (2009). Reply: Comment on alemtuzumab and inclusion body myositis. Brain. 133(5). e136–e136. 1 indexed citations

Kang, Dong‐Wha, Lawrence L. Latour, Julio A. Chalela, James M. Dambrosia, & Steven Warach. (2003). Early ischemic lesion recurrence within a week after acute ischemic stroke. Annals of Neurology. 54(1). 66–74. 92 indexed citations

Schiffmann, Raphael, Henry J. Mankin, James M. Dambrosia, et al.. (2002). Decreased Bone Density in Splenectomized Gaucher Patients Receiving Enzyme Replacement Therapy. Blood Cells Molecules and Diseases. 28(2). 288–296. 49 indexed citations

Benvenuti, Francesco, Stefania Bandinelli, Enrico Benvenuti, et al.. (1999). Kinematic characteristics of standing disequilibrium: Reliability and validity of a posturographic protocol. Archives of Physical Medicine and Rehabilitation. 80(3). 278–287. 96 indexed citations

Nelson, Karin B., James M. Dambrosia, Judith K. Grether, & Terry M. Phillips. (1998). Neonatal cytokines and coagulation factors in children with cerebral palsy. Annals of Neurology. 44(4). 665–675. 416 indexed citations

Cohen, Leonardo, Pablo Celnik, A. Pascual–Leone, et al.. (1997). Functional relevance of cross-modal plasticity in blind humans. Nature. 389(6647). 180–183. 643 indexed citations breakdown →

Schiffmann, Raphael, Melvyn P. Heyes, Johannes M. F. G. Aerts, et al.. (1997). Prospective study of neurological responses to treatment with macrophage‐targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Annals of Neurology. 42(4). 613–621. 93 indexed citations

10.

Dalakas, Marinos C., Richard H. Quarles, Robert G. Farrer, et al.. (1996). A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Annals of Neurology. 40(5). 792–795. 153 indexed citations

11.

Dinsmore, Steven, James M. Dambrosia, & Marinos C. Dalakas. (1995). A Double‐Blind, Placebo‐Controlled Trial of High‐Dose Prednisone for the Treatment of Post‐Poliomyelitis Syndrome. Annals of the New York Academy of Sciences. 753(1). 303–313. 35 indexed citations

12.

Dalakas, Marinos C., Isabel Illa, James M. Dambrosia, et al.. (1993). A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis. New England Journal of Medicine. 329(27). 1993–2000. 747 indexed citations breakdown →

13.

Higgins, Joseph, Marc C. Patterson, James M. Dambrosia, et al.. (1992). A clinical staging classification for type C Niemann‐Pick disease. Neurology. 42(12). 2286–2286. 54 indexed citations

14.

Johnson, Lewis A., Bernice E. Hoppel, Stephen P. Miller, et al.. (1992). Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.. Radiology. 182(2). 451–455. 67 indexed citations

15.

Dambrosia, James M., et al.. (1989). Protective effect of cyclohexyl adenosine in treatment of cerebral ischemia in gerbils. Neuroscience. 30(2). 451–462. 67 indexed citations

16.

Davis, Patricia H., James M. Dambrosia, Bruce S. Schoenberg, et al.. (1987). Risk factors for ischemic stroke: A prospective study in Rochester, Minnesota. Annals of Neurology. 22(3). 319–327. 118 indexed citations

17.

Ward, Christopher D., et al.. (1984). Parkinson's disease in twins.. PubMed. 40. 341–4. 38 indexed citations

18.

Dambrosia, James M. & Samuel W. Greenhouse. (1983). Early stopping for sequential restricted tests of binomial distributions.. PubMed. 39(3). 695–710. 6 indexed citations

19.

Eisler, Toomas, James M. Dambrosia, Irwin J. Kopin, & Donald B. Calne. (1981). Deprenyl in Parkinson disease. Neurology. 31(12). 1578–1578. 1 indexed citations

20.

Gross, Cynthia R. & James M. Dambrosia. (1981). Quality Assurance for Clinical Data Banks. PubMed Central. 317–321. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact